New York, N. Y., March 12, 2004 — Pfizer Inc. and its American arm (Pfizer) announced the first sales and marketing partnership for the generic version of the cholesterol drug Cozaar in the U. S.
Pfizer Inc. and its American arm (Pfizer) will launch the generic version of the cholesterol drug Cozaar on April 1, 2003, when it will be available in the U. market.
In addition to sales, Pfizer and its American arm (Pfizer) will launch the generics version of the drug, which has been the subject of intense and unprecedented competition from Pfizer’s other top-selling drugs, such as Lipitor, Crestor, and others, on the market today.
The drug is also the second-biggest selling drug in the U. to reach U. sales. The drug is the second-biggest selling drug for Pfizer, and the third-biggest selling drug worldwide. The company’s co-marketing agreement with Warner-Lambert, the third-biggest selling drug, will bring the total Pfizer sales of Cozaar to $1.2 billion in the U. and $1.6 billion in Europe.
The company will be the first company to make a generic version of the drug, and it is the first company to introduce a generic version of the drug to U. patients.
“The world is turning into a more crowded world,” said Pfizer Chief Executive Hank McKinnell. “With Pfizer’s approval of the drug, we are going to get the drugs we need, and we are going to give them the best chance we can to win.”
“We are excited for this second half of the year,” McKinnell said. “It’s going to be an exciting year. And we are hoping that we can make a successful move to bring the drugs we are offering to U. patients, to get the best out of them.”
The company will launch the Cozaar generic version of the drug in the U. on November 1, 2003, when it will be available in the U.
Pfizer will be marketing the generic drug for about two months.
The new co-marketing partnership is the second-biggest selling drug for Pfizer and the third-biggest selling drug worldwide.
The company’s new co-marketing agreement with Warner-Lambert will allow the company to market the drugs in the U. without the additional cost of the co-marketing agreement.
“This is a great opportunity to bring to market the drugs we have,” McKinnell said. “But there is the potential for additional costs and other risks associated with these medications, which we do not have access to.”
The co-marketing agreement between Pfizer and Warner-Lambert is giving Pfizer more than $2 billion in sales of the drug and $1.5 billion in sales in Europe. The co-marketing agreement with Warner-Lambert will allow Warner-Lambert to market the drug in the U. without the additional cost of co-marketing the drug.
“It is great that Pfizer has entered a new era with the drug,” McKinnell said. “But the next few years we will have a new opportunity to get the drugs we need, to get the best out of them. And we are excited about this opportunity.”
For more information on the drug, including the latest news, please visit www.pfizer.com.
About Pfizer
and its American arm (Pfizer) is a global, innovation-driven biopharmaceutical company with a strong focus on discovering, developing, and delivering innovative medicines. is a leader in the field of biopharmaceuticals and has more than 30 clinical research products in development and sales.
Cozaar is a medication that can be used to treat type 2 diabetes. The drug belongs to the class of drugs called anti-diabetic medications.
Cozaar is an oral medication that belongs to the class of drugs known as thiazolidinediones. It works by blocking the effects of certain hormones that control blood sugar in the body. These hormones include insulin, a naturally occurring hormone that can control blood sugar. By doing so, Cozaar can help decrease insulin resistance and increase the sensitivity of blood vessels to insulin.
Cozaar is indicated for the treatment of type 2 diabetes. It is commonly prescribed for the treatment of high blood sugar levels, especially in diabetic patients. It is also used to treat other conditions that are common in the elderly. It can also be prescribed for certain other conditions, such as high blood pressure, high cholesterol, and kidney disease.
Follow the instructions for your doctor or pharmacist on how to use Cozaar carefully. It is important to be aware of the dosage and duration of treatment. The dose of Cozaar can be adjusted depending on the individual response and tolerance levels.
If the dosage is not working, the doctor will prescribe a different medication. It is also important to note that Cozaar can be taken with or without food. However, if you are taking it with food, it is advisable to take it at a fixed time.
Like any medication, Cozaar can cause side effects. The most common side effects are headaches, dizziness, nausea, and fatigue. These side effects usually subside as your body adjusts to the medication. If you experience any severe side effects, such as stomach upset, you should contact a doctor immediately.
Cozaar can interact with certain other medications. This includes some antidepressants, certain antacids, and certain supplements. It is also important to inform your doctor if you are taking any other medications, including over-the-counter drugs and herbal products. It's also important to inform your doctor if you are pregnant, breastfeeding, or planning to get pregnant.
Cozaar can interact with certain drugs, such as certain antidepressants and antiepileptics. It can also interact with certain blood pressure medications, such as ACE inhibitors, ARBs, and diuretics. It's important to inform your doctor if you are taking any other medications, including over-the-counter drugs and herbal products. It is important to disclose all medications you are taking to your healthcare provider.
You should seek medical help if you experience severe side effects. Your doctor can provide you with information and support to help manage your condition more effectively.
Before starting Cozaar, inform your doctor about all the medications you are taking. This includes prescription medications, over-the-counter drugs, and herbal products. It's important to be aware of the possible interactions and warnings.
If you experience severe side effects while taking Cozaar, you should consult a doctor. They can assess your medical condition and provide advice about your treatment. In addition, they can refer you to a specialist, such as a specialist in diabetes or other health conditions.
Cozaar can be a valuable medication for managing diabetes. However, it's important to consult with a healthcare provider before starting it. They can determine whether it's appropriate for you and guide you toward the best treatment option.
Cozaar is a brand name for the medication Zithromax (azithromycin) which is used to treat a wide range of bacterial infections. It is also sometimes used to treat certain types of pneumonia, such as ear infections and skin infections, as well as sexually transmitted infections (STIs), such as chlamydia and gonorrhea. Cozaar is available in several different strengths and forms. It is important to note that Cozaar should only be taken as prescribed by a doctor, and not to be taken at any time without consulting a doctor first. In some cases, you may be prescribed a stronger dose or the addition of a second medication that is more potent and less likely to cause harm. In most cases, your doctor will determine the best dose for you based on your specific needs and will ask you to take the medication as directed. If you are taking the medication for a longer time than is necessary, your doctor may increase your dose or lower the dosage if necessary. In some cases, the doctor may decide to change the dosage of the medication to make it more convenient for you.
If you are taking Cozaar or another form of the antibiotic, you should take Cozaar exactly as directed. Follow the dosage instructions provided by your doctor or pharmacist. Do not take more than directed. Take Cozaar for the full prescribed length of time, even if your symptoms improve. Taking more than directed may increase the risk of side effects. Do not stop taking the medication without talking to your doctor first. Stopping the medication too soon may cause serious side effects, including:
The most common side effects of taking Cozaar are mild to moderate, usually transient, and usually disappear on their own after a few days of treatment. The most common side effects are gastrointestinal discomfort, including nausea, vomiting, diarrhea, and abdominal pain. Other possible side effects include:
If you experience any unusual side effects while taking Cozaar, it is important to talk to your doctor immediately. If you notice other side effects that are not listed above, or if they continue or become bothersome, contact your doctor immediately.
Store the medication at room temperature, away from heat and light. Do not freeze, and keep it out of the reach of children. Keep the medication in its original container and tightly sealed. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this and any other medications that are not in your container. It is important that you always follow the instructions on the packaging or instructions provided by your pharmacist or doctor.
Cozaarint ApprovedBy:Pharmacyndrye "Boom Head" "Treatment of angina pectoris" "Treatment of angina pectoris by the combination of losartan and finasteride."DosageBy:Hospital "Mondays" "Mon.")Method of application:Hemodialysisorshould be performed in conjunction with cozaarint approval.
The usual starting dose of losartan (Cozaar) and finasteride is one 50 mg tablet given 2 hours prior to angiography. The dose may be increased to two 200 mg tablets in the morning and one 800 mg tablet in the evening. The dose may be increased to one tablet in the morning and one pill in the evening (8-12 hours after the start of angiography).The dosage may be increased to one tablet in the morning and one pill in the evening (8-12 hours after the start of angiography) in patients taking or have taken it during a day or two prior to surgery. The duration of the effect of the drug will depend upon the clinical condition being treated, but will usually be 4 to 6 hours.
Cozaarint patients must not be used to prevent angina attacks. If an attack occurs, the patient must be hospitalized with a warning sign such as chest pain, shortness of breath, or wheezing.Patients who are taking any nitrates for chest pain or heart failure (e.g., nitroglycerin, isosorbide) should avoid this drug.Patients taking amyl nitrite or guanylate cyclase stimulators (e.g., rasagiline, tadalafil) should avoid this drug.The following conditions must be met:••Angina•Chest pain•Sudden death•DWI•Hypersensitivity •Convduction disorders•Erythema •Liver function •Renal tubular obstruction •Kidney disease•Blood clot (e.g., agranulocytosis)•Abnormal liver function •Conv>:Hypertension
Adverse Reactions/Adverse EffectsCozaarint adverse reactions/Adverse effects are the most common adverse effects for Cozaarint approved and non-approved use, with the most commonly reported and occur in 2 to 4% of patients. The list of adverse reactions/adverse effects below is general and includes all possible adverse effects. If the patient experienced a serious adverse effect while taking Cozaarint (see Precautions), an alternative therapy should be considered (e.g., diuretics or fluid restriction).
Patients should seek immediate medical attention if they experience any of the following signs of allergic reactions or allergic reactions in the preceding 3 months:• A severe rash;• A rash with itching, hives, and swelling of the face, lips, tongue, or throat;• Loss of consciousness;• Anaphylactic shock;• Seizures;• Severe skin rashes;• A sudden drop in blood pressure;• Changes in mood, thoughts, or behaviour;• Unusual bruising, bleeding, or discharge from the body;• An unusual or rash of the joint, muscle, muscle tone, or tendon.
Stade de France Pharmacy